Seborrheic Dermatitis Treatment: Evidence-Based Options That Work

Understanding Seborrheic Dermatitis Treatment: Why Single-Target Approaches Fail

Seborrheic dermatitis affects roughly 5% of adults, or about 1 in every 20 people, making it one of the most common inflammatory skin conditions worldwide. For a visual overview of how it compares to other skin conditions, see our guide to different types of eczema.^[3] Yet despite how common it is, many people struggle to control it because the underlying biology is working against them on three fronts at once.

The condition starts with Malassezia, a yeast that lives on everyone's skin. In people with seborrheic dermatitis, the immune system overreacts to this yeast, triggering inflammation in sebaceous (oil-rich) areas like the scalp, face, and chest.^[4] That inflammation damages the skin barrier, which lets more irritants in, which triggers more inflammation in a self-reinforcing loop that drives chronic disease.^[1] For background on how this cycle starts, see our guide on what causes seborrheic dermatitis.

Here is the problem with single-target treatments. Kill the yeast with an antifungal, and the inflammation may persist on its own because the immune system has already been activated.^[5] Calm the inflammation with a steroid, and the yeast keeps growing underneath. Moisturize the barrier without addressing the first two, and the cycle continues unchecked. Studies measuring transepidermal water loss (how quickly moisture escapes through the skin) confirm that the barrier itself is impaired in seborrheic dermatitis patients, with water loss roughly double that of healthy controls.^[7]

The bottom line: the most effective seborrheic dermatitis treatment plans address all three drivers (yeast, inflammation, and barrier dysfunction) at the same time.^[2]

The Three Pillars of Effective Treatment

Think of seborrheic dermatitis management as a three-legged stool: remove any leg and the stool falls over. The rest of this guide is organized around these three pillars so you can recognize which mechanism each treatment targets, and where products like multi-target lotions fit into the picture.

Research confirms that combination approaches outperform single agents for both initial clearing and long-term maintenance.^[2] The sections that follow break down each pillar so you can see exactly where every treatment fits.

Antifungal Treatments: Targeting Malassezia

If you have ever noticed that flakes and redness keep returning to the same oily spots, that is Malassezia at work. Because this yeast drives the chain reaction of inflammation, antifungal therapy forms the foundation of most treatment plans. These agents disrupt the yeast's cell membrane or block its ability to reproduce, much like poking holes in a balloon so it can no longer hold air.^[8] The right choice depends on where your symptoms appear and how severe they are.

Topical Antifungal Creams

Topical antifungals are the first-line choice for seborrheic dermatitis on the face and body, and they are the most-studied category in the entire treatment toolkit.

• Ketoconazole 2% cream: The gold standard. A Cochrane review of multiple randomized trials found ketoconazole reduced the risk of failed clearance by 31% versus placebo at four weeks, with side-effect rates 44% lower than topical steroids.^[9] A 2025 head-to-head trial showed SEDASI scores dropping from 9.94 at baseline to 0.70 after two months, which is near-complete clearance.^[31] It works by blocking ergosterol synthesis, which collapses the yeast's cell membrane like puncturing a water balloon.^[8]
• Ciclopirox 1% cream: Inhibits fungal metal-dependent enzymes, damaging mitochondria and membranes. Cochrane data show ciclopirox is 21% more effective than placebo with comparable efficacy to ketoconazole.^[10]
• Ivermectin 1% cream: A newer option. In a 2025 double-blind RCT, once-nightly ivermectin matched twice-daily ketoconazole for SEDASI reduction, erythema, itch, and quality of life.^[31]
• Clotrimazole 1% cream: A widely available imidazole that also blocks ergosterol synthesis, though less specifically studied for seborrheic dermatitis than ketoconazole.^[8]

Most dermatologists recommend twice-daily application for two to four weeks during active flares, then tapering to once or twice weekly to keep symptoms from returning.^[9]

Medicated Shampoos at a Glance

For scalp involvement, medicated shampoos deliver antifungal agents directly where you need them. Contact time matters: most shampoos work best when left on for three to five minutes before rinsing.^[11] If you have been lathering and rinsing immediately, that alone could explain why your shampoo has not worked.

Because scalp-specific protocols sit slightly outside this pillar guide, we cover lathering technique, contact time, and rotation patterns in depth in our companion article on scalp eczema treatment. For condition-specific application guidance, the SmartLotion help center also provides a dedicated scalp scaling and itching protocol.

Oral Antifungals for Severe or Resistant Cases

When topical treatments fail, oral antifungals can help. Doctors reserve these for widespread or treatment-resistant disease because they carry more risk.

• Itraconazole: Often used as pulse therapy — 200 mg daily for one week, then 200 mg on the first two days of each month for two months. Studies show complete clearing or marked improvement in about 67% of patients.^[8]
• Terbinafine: 250 mg daily for four to six weeks. In a head-to-head trial, terbinafine reduced SDASI scores more than fluconazole, though both were effective.^[14]
• Fluconazole: 300 mg weekly for two to four weeks offers a convenient alternative dosing schedule.^[14]

Oral antifungals address only one pillar. Even when they clear your skin, you will still need an anti-inflammatory and barrier-support plan to prevent relapse. Controlling yeast is only the first step, because the next critical piece is calming the immune overreaction that creates the redness and itch you actually see and feel.

Anti-Inflammatory Treatments: Calming the Immune Response

Even after you knock back the yeast, you may still wake up to that familiar tightness and flaking. That is because the immune system's overreaction is what produces the redness, scaling, and itch that make seborrheic dermatitis so visible. In fact, the persistence of relief after antifungal therapy remains uncertain in clinical reviews; inflammation can smolder on even after Malassezia is controlled.^[5] Anti-inflammatory treatments target this second pillar directly.

Topical Corticosteroids: Matching Potency to Body Site

Topical steroids remain the fastest way to reduce inflammation in seborrheic dermatitis. They suppress local immune activity and reduce cytokines (the chemical messengers that fuel inflammation), essentially turning down the volume on the skin's alarm system. Understanding how steroids fit into the broader landscape of atopic dermatitis treatments can help you see why dermatologists use them selectively.^[8] The critical rule: match potency to body site, because facial skin is dramatically thinner than skin elsewhere.^[24]

• Face and skin folds: Low-potency only (hydrocortisone 1%, desonide 0.05%). One trial found 1% hydrocortisone slightly outperformed 2% ketoconazole at four weeks, but prolonged facial use is not recommended.^[8]
• Scalp: Potent or super-potent agents (betamethasone valerate 0.12% foam, clobetasol propionate 0.05% shampoo) for short courses.^[8]
• Body (chest, back): Moderate potency for short courses. Limit to two weeks at a time.^[8]

Prolonged facial steroid use causes a recognized pattern of harm. In a study of 316 patients with topical steroid-induced facial dermatosis, 45.2% had steroid-induced acne, 21.2% had erythema and telangiectasia, and 1.5% had visible atrophic scars.^[16] For more on the consequences of extended steroid use, see our article on topical steroid withdrawal.

This is exactly why dermatologists look for steroid-sparing alternatives, especially for a chronic condition that requires ongoing management.

Calcineurin Inhibitors: The Steroid-Sparing Standard

Calcineurin inhibitors offer anti-inflammatory power without the skin-thinning risk of steroids. They work by blocking an enzyme called calcineurin, which normally tells T-cells (immune cells that drive inflammation) to release inflammatory signals.^[17] Crucially, they leave blood vessels and the cells that build connective tissue alone, so they do not cause skin thinning or the spidery broken vessels that long-term steroid use can produce.^[17]

• Pimecrolimus 1% cream: A systematic review of randomized trials concluded pimecrolimus offers "considerable desirable control" of facial seborrheic dermatitis with lower relapse rates, and is recommended as a steroid-sparing option.^[18]
• Tacrolimus 0.1% ointment: In a multicenter maintenance study, 63.6% of facial seborrheic dermatitis patients applying tacrolimus twice weekly remained disease-free over 20 weeks, compared with 0% of the placebo group.^[6] Median time to first exacerbation was 41 days vs. 18 days with placebo.^[6]

The main downside is transient burning or stinging in the first few days, which usually fades within a week.^[18] For most patients managing facial seb dermatitis treatment long-term, dermatologists now consider calcineurin inhibitors the preferred option. Learn more about facial-specific care in our facial eczema treatment guide.

Emerging Anti-Inflammatory Options

Newer agents are expanding the toolkit and reshaping what effective treatment for seborrheic dermatitis can look like:

• Roflumilast 0.3% foam: A highly selective PDE4 inhibitor. In a Phase 2a randomized trial, 73.8% of roflumilast-treated patients achieved IGA success at week 8, versus 40.9% on vehicle, with adverse event rates similar to placebo.^[19]
• Topical JAK inhibitors: Block a signaling pathway (JAK-STAT) that drives several cytokines tied to inflammation and itch. Ruxolitinib 1.5% cream achieved a 71.6% improvement in eczema severity scores in atopic dermatitis trials, and investigation in seborrheic dermatitis is ongoing.^[20]

These emerging options target inflammation through pathways entirely different from steroids or calcineurin inhibitors. But most people need solutions available right now, which is why your over-the-counter options matter just as much as what is in the pipeline.

OTC Treatment Options: From Moisturizers to All-in-One Solutions

Standing in a drugstore aisle staring at dozens of creams and lotions, it is hard to know which ones actually do anything for seborrheic dermatitis. These products fall into distinct categories with very different capabilities, so understanding those categories helps you avoid wasting money on products that cannot address your specific needs.

OTC Moisturizers and Prebiotic Moisturizers

Moisturizers play a supporting role. Research shows the skin barrier is compromised in affected areas, with moisture loss roughly double that of healthy skin.^[7] Emollients help restore that barrier by filling in the gaps, like patching cracks in a wall to slow heat loss.

However, moisturizers alone cannot treat active seborrheic dermatitis because they do not reduce Malassezia or calm the immune response. Some heavy, occlusive moisturizers can actually worsen symptoms, since Malassezia is lipid-dependent and increased skin lipids favor yeast overgrowth. For guidance on choosing the right moisturizer formulation, see our article on whether lotion helps eczema.^[21] For a deeper look at moisturizer mechanics, see our guide on how moisturizers work.

Prebiotic moisturizers go one step further by supporting beneficial skin commensals while feeding fewer Malassezia-friendly lipids. Microbiome-targeted products are increasingly recognized as part of the seborrheic dermatitis toolkit, with prebiotics, probiotics, and postbiotics each showing promise for restoring microbial balance.^[22]

OTC Hydrocortisone 1%: Why It Falls Short

Over-the-counter hydrocortisone 1% is the most widely available non-prescription anti-inflammatory option. It can provide mild, temporary relief — but for seborrheic dermatitis specifically, it has real limitations.^[32]

• Low potency only: It is the weakest class of topical steroid and often cannot control moderate flares on its own.^[8]
• No antifungal action: It does nothing to address Malassezia, so the underlying trigger persists.
• Duration limits: Even at this low potency, continuous facial use beyond two weeks raises concerns about steroid-induced facial dermatosis.^[16]

This leaves a real gap in the OTC market. You can buy a moisturizer (barrier only), a medicated shampoo (antifungal only for scalp), or a weak steroid (mild anti-inflammatory only). Until recently, no single OTC product addressed all three pillars in one application.

SmartLotion: Addressing All Three Treatment Pillars

SmartLotion was developed by a board-certified dermatologist specifically to fill this gap. It combines a low-dose anti-inflammatory with prebiotic technology and a moisturizing base, addressing all three pillars of seborrheic dermatitis treatment in one formulation.

• Anti-inflammatory: A carefully calibrated dose of hydrocortisone designed for safe, long-term daily use.
• Microbiome support: Prebiotic ingredients help restore healthy skin microbial balance, which is disrupted in seborrheic dermatitis with elevated Staphylococcus and Malassezia and reduced commensal species.^[22]
• Barrier repair: The moisturizing base supports skin barrier function without the heavy occlusion that can feed yeast.^[21]

For detailed application instructions specific to seborrheic dermatitis, see the SmartLotion seborrheic dermatitis treatment protocol. If you are wondering how SmartLotion differs from standard store-bought hydrocortisone, see how SmartLotion is different from OTC hydrocortisone.

This is what separates a true cream for seborrheic dermatitis from a simple moisturizer. The multi-target approach mirrors what dermatologists recommend in prescription regimens, but in an accessible over-the-counter format.^[2] For people managing seborrheic dermatitis on the face or body, a seborrheic dermatitis lotion that combines all three pillars removes the guesswork of layering separate products.

Natural and Complementary Approaches

If you have searched online for natural seborrheic dermatitis remedies, you have seen everything from tea tree oil to colloidal silver recommended with equal confidence. In reality, only a handful have credible clinical evidence — and they belong in the toolkit as adjuncts, not replacements.

Natural remedies can complement conventional treatment, but they rarely replace it for moderate to severe cases. For a broader look at how diet and nutrition interact with inflammatory skin conditions, see our guide on diet and eczema.

Long-Term Management and Flare Prevention

Here is the honest truth: no permanent cure exists. Malassezia is a normal part of your skin's ecosystem, and the immune tendency to overreact to it is likely partly genetic.^[4] But "no cure" does not mean "no control." Managing seborrheic dermatitis is more like managing blood pressure than fighting an infection. You don't beat it once and walk away, but with the right maintenance strategy, most people stay flare-free for months or years at a time. For a broader perspective on living with a chronic skin condition, see our guide on living with eczema.

Building Your Maintenance Routine

The goal of maintenance is to keep Malassezia low, inflammation quiet, and the barrier intact. Studies repeatedly show maintenance dramatically reduces relapse: 19% of patients on weekly ketoconazole shampoo relapsed compared with 47% on placebo,^[11] and tacrolimus maintenance kept 63.6% of facial SD patients exacerbation-free over 20 weeks.^[6]

When Treatment Stops Working: Rotation Strategies

If a treatment that once worked stops being effective, you are not imagining things. Malassezia can develop reduced susceptibility to antifungals over time, and inflammatory pathways can shift.^[8] For guidance on stubborn lesions, see our article on leftover patches that won't clear.

• Rotate shampoo actives: Switch between ketoconazole, ciclopirox, zinc pyrithione, and selenium sulfide every one to two months.^[11]
• Alternate anti-inflammatory agents: If a calcineurin inhibitor loses effectiveness, a short steroid course can reset the response, then switch back.
• Reassess the diagnosis: Treatment failure sometimes means the diagnosis needs another look. Sebopsoriasis (overlap with scalp psoriasis), tinea, and contact dermatitis can all mimic seborrheic dermatitis. See our guide on the difference between psoriasis and eczema.

Seborrheic dermatitis is a condition you manage, not one you defeat once and forget. Recognizing when you need professional help is part of that management.

When to See a Dermatologist

Most mild-to-moderate seborrheic dermatitis responds to the approaches above, but certain situations call for professional evaluation.

Frequently Asked Questions About Seborrheic Dermatitis Treatment

What is the best treatment for seborrheic dermatitis?

The best treatment addresses all three drivers at once: Malassezia yeast, inflammation, and barrier dysfunction. For most people, that means combining an antifungal (ketoconazole 2% cream or medicated shampoo) with an anti-inflammatory agent and a barrier-supporting moisturizer.^[2] For an OTC option that delivers all three pillars in one product, SmartLotion was specifically designed for conditions like seborrheic dermatitis, while prescription options such as calcineurin inhibitors or roflumilast may be needed for moderate to severe cases.^[19]

Is there a permanent cure for seborrheic dermatitis?

No. Seborrheic dermatitis is a chronic condition driven by an immune response to Malassezia, which is a normal part of skin ecology.^[4] Effective long-term control is absolutely achievable, however. Maintenance studies show 63–65% of patients stay disease-free for months on twice-weekly maintenance therapy.^[6] The goal shifts from "curing" to managing so effectively that flares rarely affect daily life.

How do you calm a seborrheic dermatitis flare-up?

To calm an active flare quickly:

1. Apply a topical antifungal (ketoconazole 2% or ivermectin 1% cream) twice daily.^[31]
2. Use a short course of a low-potency steroid (hydrocortisone 1% or desonide) for up to two weeks to reduce redness and itch.^[8]
3. For scalp flares, use a medicated shampoo with 3–5 minutes of contact time.^[11]
4. Consider an effective seborrheic dermatitis cream like SmartLotion that targets inflammation, microbiome balance, and barrier repair simultaneously.

Most flares begin improving within one to two weeks of consistent treatment.^[2]

What are the most effective treatments for seborrhoeic dermatitis?

The most effective treatments for seborrhoeic dermatitis combine evidence from multiple Cochrane reviews and randomized trials. Topical ketoconazole 2% reduces failed clearance by 31% versus placebo,^[9] ciclopirox 1% by 21%.^[10] Tacrolimus 0.1% ointment delivers 63.6% disease-free maintenance at 20 weeks.^[6] Roflumilast 0.3% foam produces 73.8% IGA success at week 8.^[19] For severe or resistant cases, oral itraconazole pulse therapy clears or markedly improves 67% of patients.^[8] The thread connecting all of them is that combinations targeting multiple pillars outperform any single agent alone.^[2]

How long does seborrheic dermatitis treatment take to work?

Most topical treatments produce visible improvement within one to two weeks. Significant clearing typically occurs by weeks three to four with consistent use — in ketoconazole shampoo trials, 89% of patients were improved or lesion-free at four weeks compared with 44% on placebo.^[11] If you see no improvement after four weeks of consistent treatment, see a dermatologist to confirm the diagnosis and adjust your approach.

References

1. Xu Y, Tong X. "The dual roles of T cells and keratinocytes in seborrheic dermatitis: a narrative review." European Journal of Medical Research. 2025. View Study
2. Dall'Oglio F, Lacarrubba F, Verzì AE, Micali G. "Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation." Skin Appendage Disorders. 2016. View Study
3. Lu YY, Lu CC, Tsai CY, Liu YJ, Huang CL, Wang WT, Wu CH. "Impact of seborrheic dermatitis on osteoporosis risk: A population-based cohort study." The Journal of Dermatology. 2022. View Study
4. Piacentini F, Camera E, Di Nardo A, Dell'Anna ML. "Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia." International Journal of Molecular Sciences. 2025. View Study
5. Chong AC, Navarro-Triviño FJ, Su M, Park CO. "Fungal Head and Neck Dermatitis: Current Understanding and Management." Clinical Reviews in Allergy & Immunology. 2024. View Study
6. Kim HO, Yang YS, Ko HC, Kim GM, Cho SH, Seo YJ, Son SW, Lee JR, Lee JS, Chang SE, Che JW, Park CW. "Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment." Annals of Dermatology. 2015. View Study
7. An Q, Sun M, Qi RQ, Zhang L, Zhai JL, Hong YX, Song B, Chen HD, Gao XH. "High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis." Chinese Medical Journal. 2017. View Study
8. Dall'Oglio F, Nasca MR, Gerbino C, Micali G. "An Overview of the Diagnosis and Management of Seborrheic Dermatitis." Clinical, Cosmetic and Investigational Dermatology. 2022. View Study
9. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. "Topical antifungals for seborrhoeic dermatitis." Cochrane Database of Systematic Reviews. 2015. View Study
10. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. "Topical antifungals for seborrhoeic dermatitis." Cochrane Database of Systematic Reviews. 2015. View Study
11. Tynes BE, Johnson CD, Vaish MH, Abbott B, Vučenović J, Varrassi G, Potharaju P, Lopez Torres Y, Lee Z, Ahmadzadeh S, Shekoohi S, Kaye AD. "Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review." Cureus. 2024. View Study
12. Massiot P, Clavaud C, Thomas M, et al. "Continuous clinical improvement of mild-to-moderate seborrheic dermatitis and rebalancing of the scalp microbiome using a selenium disulfide-based shampoo after an initial treatment with ketoconazole." Journal of Cosmetic Dermatology. 2022. View Study
13. McLean WH, Irvine AD. "Old King Coal — molecular mechanisms underlying an ancient treatment for atopic eczema." The Journal of Clinical Investigation. 2013. View Study
14. Alizadeh N, Monadi Nori H, Golchi J, Eshkevari SS, Kazemnejad E, Darjani A. "Comparison the Efficacy of Fluconazole and Terbinafine in Patients with Moderate to Severe Seborrheic Dermatitis." Dermatology Research and Practice. 2014. View Study
15. Feldman WB, Mahesri M, Sarpatwari A, et al. "Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan." JAMA Network Open. 2024. View Study
16. Jain S, Mohapatra L, Mohanty P, Jena S, Behera B, et al. "Study of Clinical Profile of Patients Presenting with Topical Steroid-Induced Facial Dermatosis to a Tertiary Care Hospital." Indian Dermatology Online Journal. 2020. View Study
17. Lampropoulos CE, D'Cruz DP. "Topical calcineurin inhibitors in systemic lupus erythematosus." Therapeutics and Clinical Risk Management. 2010. View Study
18. Alsmeirat O, Lakhani S, Egaimi M, Idris O, Elkhalifa M. "The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials." Cureus. 2022. View Study
19. Zirwas MJ, Draelos ZD, DuBois J, et al. "Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial." JAMA Dermatology. 2023. View Study
20. Chovatiya R, Paller AS. "JAK Inhibitors in the Treatment of Atopic Dermatitis." Journal of Allergy and Clinical Immunology. 2021. View Study
21. Vijaya Chandra SH, Srinivas R, Dawson TL Jr, Common JE. "Cutaneous Malassezia: Commensal, Pathogen, or Protector?" Frontiers in Cellular and Infection Microbiology. 2021. View Study
22. Rušanac A, Škibola Z, Matijašić M, Čipčić Paljetak H, Perić M. "Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases." International Journal of Molecular Sciences. 2025. View Study
23. Saxena R, Mittal P, Clavaud C, Dhakan DB, Roy N, Breton L, Misra N, Sharma VK. "Longitudinal study of the scalp microbiome suggests coconut oil to enrich healthy scalp commensals." Scientific Reports. 2021. View Study
24. Jeong KM, Seo JY, Kim A, Kim YC, Baek YS, Oh CH, Jeon J. "Ultrasonographic analysis of facial skin thickness in relation to age, site, sex, and body mass index." Skin Research and Technology. 2023. View Study
25. Mohammed H. "Anti-inflammatory properties of raw honey and its clinical applications in daily practice." Qatar Medical Journal. 2022. View Study
26. Kashiri A, Maghsoudloo N. "Exploring the Impact of Vitamin D and Zinc Deficiencies on Seborrheic Dermatitis: A Comparative Study." Health Science Reports. 2025. View Study
27. Truglio M, Sivori F, Cavallo I, Abril E, Licursi V, Fabrizio G, Cardinali G, Pignatti M, Toma L, Valensise F, Cristaudo A, Pimpinelli F, Di Domenico EG. "Modulating the skin mycobiome-bacteriome and treating seborrheic dermatitis with a probiotic-enriched oily suspension." Scientific Reports. 2024. View Study
28. Calder PC. "Omega-3 Fatty Acids and Inflammatory Processes." Nutrients. 2010. View Study
29. Anshory M, Effendi RMRA, Rosandy MG, Kalim H, Nijsten TEC, Schappin R, Nouwen JL, Thio HB. "Dermatological manifestation of HIV infection: systematic review and meta-analysis." BMC Infectious Diseases. 2025. View Study
30. Lipner SR, Gupta AK, Joseph WS, Elewski B, Guenin E, Vlahovic TC. "Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials." Mycoses. 2025. View Study
31. "Comparison of the Effectiveness of Ivermectin 1% Cream and Ketoconazole 2% Cream in Treating Facial Seborrheic Dermatitis: A Double-Blind, Randomized, Controlled Clinical Trial." Health Science Reports. 2025. View Study
32. Qeyam H, Al-Shaimi R, Abed Alfattah N, Almomani EY, Al-Rusan A, Muhaidat J, Alshiyab D, Al-Qarqaz F, Heis L. "The Hidden Epidemic of Topical Steroid Use: Prevalence and Impact Among Jordan's General Population." Clinical, Cosmetic and Investigational Dermatology. 2025. View Study